We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protein Purification: Chromatography and Scalability in Biopharma

Article   Nov 21, 2017 | by Laura Elizabeth Mason, Science Editor, Technology Networks

 
Protein Purification: Chromatography and Scalability in Biopharma

Laura Mason

Science Writer

 
 
 

RELATED ARTICLES

The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020

Article

The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a compound annual growth rate (CAGR) of 49.1% during the forecast period 2015 to 2020, according to Allied Market Research’s report.

READ MORE

UHPLC- Robust Technology Built to Perform

Article

Chromatography is the backbone of analytical laboratories with high performance liquid chromatography (HPLC) representing the largest portion. Classical HPLC has been challenged - or complemented - in the last decade by ultrahigh performance liquid chromatography (UHPLC).

READ MORE

Optimizing Starting Material Quality for Cellular Therapeutics

Article

When a company strives to make an excellent product, they start with the highest quality materials. Cell therapy is unique in that the building blocks for the “product” are living human cells; since each donor is unique, variability is inevitable. Choosing optimal apheresis instrumentation and collection methods is one of the most important steps in ensuring high-quality starting material.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE